EP3233096A4 - Traitement de la dégénérescence rétinienne avec des cellules progénitrices - Google Patents

Traitement de la dégénérescence rétinienne avec des cellules progénitrices Download PDF

Info

Publication number
EP3233096A4
EP3233096A4 EP15870680.4A EP15870680A EP3233096A4 EP 3233096 A4 EP3233096 A4 EP 3233096A4 EP 15870680 A EP15870680 A EP 15870680A EP 3233096 A4 EP3233096 A4 EP 3233096A4
Authority
EP
European Patent Office
Prior art keywords
treatment
progenitor cells
retinal degeneration
retinal
degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15870680.4A
Other languages
German (de)
English (en)
Other versions
EP3233096A2 (fr
Inventor
Ian Harris
Jing Cao
Nadine Sophia DEJNEKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of EP3233096A2 publication Critical patent/EP3233096A2/fr
Publication of EP3233096A4 publication Critical patent/EP3233096A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP15870680.4A 2014-12-16 2015-12-04 Traitement de la dégénérescence rétinienne avec des cellules progénitrices Withdrawn EP3233096A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462092658P 2014-12-16 2014-12-16
US201562236732P 2015-10-02 2015-10-02
PCT/US2015/063931 WO2016099949A2 (fr) 2014-12-16 2015-12-04 Traitement de la dégénérescence rétinienne avec des cellules progénitrices

Publications (2)

Publication Number Publication Date
EP3233096A2 EP3233096A2 (fr) 2017-10-25
EP3233096A4 true EP3233096A4 (fr) 2018-08-22

Family

ID=56110114

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15870680.4A Withdrawn EP3233096A4 (fr) 2014-12-16 2015-12-04 Traitement de la dégénérescence rétinienne avec des cellules progénitrices

Country Status (15)

Country Link
US (1) US20160166619A1 (fr)
EP (1) EP3233096A4 (fr)
JP (1) JP2018500325A (fr)
KR (1) KR20170094368A (fr)
CN (1) CN107249608A (fr)
AU (1) AU2015363088A1 (fr)
BR (1) BR112017012581A2 (fr)
CA (1) CA2970641A1 (fr)
MX (1) MX2017007953A (fr)
PH (1) PH12017501028A1 (fr)
RU (1) RU2017124983A (fr)
SG (1) SG11201704668PA (fr)
TW (1) TW201632620A (fr)
WO (1) WO2016099949A2 (fr)
ZA (1) ZA201704793B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2017095991A1 (fr) * 2015-12-04 2017-06-08 Janssen Biotech, Inc. Traitement de la dégénérescence rétinienne à l'aide de cellules progénitrices
JP6799248B2 (ja) * 2016-09-28 2020-12-16 澁谷工業株式会社 細胞シートの切断方法
WO2018102174A1 (fr) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Traitement de la dégénérescence rétinienne à l'aide de cellules progénitrices
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CN109456937A (zh) * 2018-12-27 2019-03-12 广州赛莱拉干细胞科技股份有限公司 一种制备子宫内膜干细胞的培养基以及制备方法
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
WO2021207282A2 (fr) 2020-04-07 2021-10-14 Combangio, Inc. Sécrétome dérivé de cellules souches mésenchymateuses lyophilisées et utilisations associées
CN112156172B (zh) * 2020-10-26 2022-11-25 上海交通大学医学院附属第九人民医院 血小板反应蛋白1在制备预防和/或治疗年龄相关性黄斑变性的药物中的应用
CN115177717B (zh) * 2022-08-31 2026-02-06 贵州医科大学附属医院 一种治疗眼表及角膜上皮疾病的药物
CN117004554B (zh) * 2023-08-09 2026-01-06 北京燕麝生物科技发展有限公司 一种林麝香腺细胞的培养基及林麝香腺细胞的培养方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof
US20140154226A1 (en) * 2003-06-27 2014-06-05 DePuy Synthes Products, LLC Regeneration and repair of neural tissue using postpartum-derived cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001080A2 (fr) * 2003-06-27 2005-01-06 Ethicon, Incorporated Cellules derivees de tissus post-partum destinees a etre utilisees pour traiter des maladies du coeur et du systeme circulatoire

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100272803A1 (en) * 2003-06-27 2010-10-28 Sanjay Mistry Repair and regeneration of ocular tissue using postpartum-derived cells
US20140154226A1 (en) * 2003-06-27 2014-06-05 DePuy Synthes Products, LLC Regeneration and repair of neural tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LUND R D ET AL: "Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease", STEM CE, ALPHAMED PRESS, DAYTON, OH, US, vol. 25, no. 3, 1 April 2007 (2007-04-01), pages 602 - 611, XP009087718, ISSN: 1066-5099 *

Also Published As

Publication number Publication date
JP2018500325A (ja) 2018-01-11
CN107249608A (zh) 2017-10-13
CA2970641A1 (fr) 2016-06-23
ZA201704793B (en) 2019-01-30
PH12017501028A1 (en) 2018-03-05
US20160166619A1 (en) 2016-06-16
AU2015363088A1 (en) 2017-06-15
MX2017007953A (es) 2018-02-09
TW201632620A (zh) 2016-09-16
SG11201704668PA (en) 2017-07-28
EP3233096A2 (fr) 2017-10-25
WO2016099949A2 (fr) 2016-06-23
RU2017124983A (ru) 2019-01-17
BR112017012581A2 (pt) 2017-12-26
RU2017124983A3 (fr) 2019-06-05
KR20170094368A (ko) 2017-08-17

Similar Documents

Publication Publication Date Title
EP3233096A4 (fr) Traitement de la dégénérescence rétinienne avec des cellules progénitrices
EP3145875A4 (fr) Procédés de traitement électrochimique
IL285258A (en) Retinal ganglion cells and their progenitor cells
EP3119401A4 (fr) Cenicriviroc pour le traitement de la fibrose
EP3240612A4 (fr) Procédés de traitement de maladies rétiniennes
GB201403260D0 (en) Treatment of retinal degeneration using gene therapy
EP3092008A4 (fr) Probiotique pour la peau
EP3138906A4 (fr) Cellules progénitrices cardiaques positives pour le cd82
EP3157504A4 (fr) Compositions stimulant les cellules souches et procédés
EP3089748A4 (fr) Traitement de la néovascularisation oculaire
EP3213762A4 (fr) Nouveau traitement de la cornée employant de la laminine
EP3145543A4 (fr) Traitement des affections associées aux éosinophiles ou aux mastocytes
EP3233174A4 (fr) Administration intraoculaire de molécules bioactives par iontophorèse
EP3213761A4 (fr) Nouveau traitement de la rétine et des nerfs utilisant la laminine
EP3229813A4 (fr) Traitement d'une l'inflammation médiée par hmgb1
EP3148556A4 (fr) Préparations de traitement de la peau
ZA201704521B (en) Treatment of ocular conditions using progenitor cells
EP3209131A4 (fr) Compositions et méthodes de traitement avec l'hémopexine
EP3225134A4 (fr) Chaise
EP3384009A4 (fr) Traitement de la dégénérescence rétinienne à l'aide de cellules progénitrices
EP3179886A4 (fr) Chaise
EP3145525A4 (fr) Utilisation de microperoxidases pour le traitement de la carboxyhémoglobinémie
EP3226808A4 (fr) Implants intra-cornéens et leurs procédés d'utilisation
EP3226883A4 (fr) Compositions et méthodes de traitement de maladies dégénératives de la rétine
HK1262170A1 (en) Treatment of retinal degeneration using progenitor cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20170707

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180723

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/51 20150101AFI20180717BHEP

Ipc: A61K 35/14 20150101ALI20180717BHEP

Ipc: A61P 27/02 20060101ALI20180717BHEP

Ipc: A61K 48/00 20060101ALI20180717BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200701